Delivery Order SPE2DB20D2014-SPE2DB24FB50U
Award Date 4/3/24
Potential Completion Date 4/4/24
Potential Value $1.1K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,836.58, is for the delivery of Fenofibrate 145 mg tablets in quantities of 500 per bottle. The contract is a firm fixed-price delivery order with a period of performance through February 24, 2025. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,301.09, is for the delivery of Fenofibrate 145 mg tablets. It is a firm fixed-price delivery order contract with a period of performance through March 13, 2025. The contract has no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $107,703.25, is for the delivery of Fenofibrate 145 mg tablets over the period ending on April 4, 2025. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a $3,410.24 firm fixed price delivery order (SPE2DB22D3011|SPE2DB24FQ0PL) to AmerisourceBergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4564261717 Fenofibrate 145 mg Tablets. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded to AmerisourceBergen Drug Corp to provide a comprehensive range of pharmaceutical products and...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $29,752.53 for 90-count bottles of Fenofibrate 145 mg tablets under a firm fixed price contract. This award, issued on November 5, 2025, with an ultimate completion date of November 6, 2025, represents a non-competitive set-aside delivery order for pharmaceutical supply to support federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $24,832.85 to AmerisourceBergen Drug Corp for the supply of Fenofibrate 145 mg tablets (90-count units) on August 26, 2025, with completion scheduled for August 27, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and designates AmerisourceBergen's Conshohocken, Pennsylvania location as the place of performance. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $39,887.11 firm fixed price delivery order to AmerisourceBergen Drug Corp for Fenofibrate 145 mg tablets (90-count supply) with an ultimate completion date of June 3, 2025. This non-set-aside award was competitively awarded to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's broader Indefinite Delivery Contract relationship with the DLA....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $36,658.44 firm-fixed-price delivery order is for the supply of Fenofibrate 145 mg tablets. The contract has an ultimate completion date of May 14, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00. This prime...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Fenofibrate 48 mg tablets. The contract has a ceiling value of $1,713.70 and is a firm fixed price delivery order with an ultimate completion date of August 22, 2024. The contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 with the DLA Troop Support Medical for the delivery of a wide...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Fenofibrate 40 mg tablets. The contract, which is not set aside, has a ceiling value of $1,409.52 and a performance period through June 10, 2025. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB24FB50UDelivery Order
This is a firm fixed price delivery order awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,068.36, is for the supply of 4564160110 - Fenofibrate 145 mg tablets in 90-count bottles. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA with a potential value of $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for Amerisourcebergen to provide a range of pharmaceutical products and medical supplies to support military treatment programs and facilities worldwide. The current delivery order was not set aside for any specific business category.
Generated 7/3/24, 10:03 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 4/3/24 |